Not Tagged
Not Tagged
['lymsm']
#ash22 #lymsm illerhaus: toxicities favored r-devic but pfs (79% with asct v 53% with r-devic at 3 years w median 45mo followup) and os (86% v 71% at 3 years) superior with asct (current standard at many but not all us centers). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)